Home
Conditions
Neoplasms, Germ Cell and Embryonal

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,099 public trials 1,231 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Recruiting

18F-DOPA II - PET Imaging Optimization

NCT04706910

Conditions: Basal Ganglia Diseases, Brain Diseases, Brain Neoplasms, +36 more
Locations: WC Mackenzie Health Science Centre / University of Alberta Hospital Edmonton, Alberta, Canada

View Trial Details

Recruiting

Engineering Immune Organoids to Study Pediatric Cancer

NCT05890781

Conditions: Adenocarcinoma, Brain Diseases, Brain Neoplasms, +30 more
Locations: Gustave Roussy Villejuif, France

Hopital Necker Paris, Île-de-France Region, France

View Trial Details

Recruiting

Evaluation of the CONVIVO System

NCT05139277

Conditions: Astrocytoma, Brain Diseases, Brain Metastases, +32 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Recruiting

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

NCT06548789

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

5G-PEARL: Paxalisib in Malignant Brain Tumours

NCT07391215

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme (GBM), +9 more
Locations: Royal Marden NHS Foundation Trust Sutton, United Kingdom

View Trial Details

Recruiting

Pharmaceutical Management in Targeted Radioligand Therapy

NCT07389512

Conditions: Adenocarcinoma, Cancer, Carcinoid Tumor, +25 more
Locations: Hospices Civils de Lyon Bron, France

CGFL Dijon Dijon, France

Centre Hospitalier Universitaire de Lille Lille, France

View Trial Details

Recruiting

Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.

NCT05027386

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Yizhuo Zhang Guangzhou, Guangdong, China

View Trial Details

Recruiting

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

NCT05139095

Conditions: Female Urogenital Diseases and Pregnancy Complications, Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, +7 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations: The Angeles Clinic and Research Institute Los Angeles, California, United States

START Midwest Grand Rapids, Michigan, United States

START-New York Long Island Lake Success, New York, United States

Providence Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

NCT05476939

Conditions: Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +17 more
Locations: Aarhus Universitetshospital Skejby Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

H.C. Andersen Children's Hospital, Odense Universitetshospital Odense, Denmark

Gustave Roussy Villejuif, Val de Marne, France

View all 50 locations

View Trial Details

Neoplasms, Germ Cell and Embryonal

Neoplasms, Germ Cell and Embryonal trial results

Related conditions